545 related articles for article (PubMed ID: 19591227)
21. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
[TBL] [Abstract][Full Text] [Related]
22. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model.
Aupperle H; Garbade J; Schubert A; Barten M; Dhein S; Schoon HA; Mohr FW
Vet Pathol; 2007 Jul; 44(4):494-503. PubMed ID: 17609194
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells' interaction with skin: wound-healing effect on fibroblast cells and skin tissue.
Jeon YK; Jang YH; Yoo DR; Kim SN; Lee SK; Nam MJ
Wound Repair Regen; 2010; 18(6):655-61. PubMed ID: 20955344
[TBL] [Abstract][Full Text] [Related]
24. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 counteracts effects of cyclosporin A on extracellular matrix metabolism by human dermal fibroblasts.
Abe M; Yokoyama Y; Syuto T; Ishibuchi H; Ishikawa O
Cell Tissue Res; 2008 Aug; 333(2):281-8. PubMed ID: 18553108
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
[TBL] [Abstract][Full Text] [Related]
28. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin.
Ghaffari A; Li Y; Karami A; Ghaffari M; Tredget EE; Ghahary A
J Cell Biochem; 2006 May; 98(2):383-93. PubMed ID: 16440305
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the extracellular matrix remodeling by lutein in dermal fibroblasts, melanoma cells, and ultraviolet radiation exposed fibroblasts.
Philips N; Keller T; Hendrix C; Hamilton S; Arena R; Tuason M; Gonzalez S
Arch Dermatol Res; 2007 Oct; 299(8):373-9. PubMed ID: 17710425
[TBL] [Abstract][Full Text] [Related]
31. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
[TBL] [Abstract][Full Text] [Related]
32. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.
Sessions DR; Vick MM; Fitzgerald BP
J Anim Sci; 2009 Dec; 87(12):3955-66. PubMed ID: 19684269
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells suppress fibroblast proliferation and reduce skin fibrosis through a TGF-β3-dependent activation.
Wu Y; Peng Y; Gao D; Feng C; Yuan X; Li H; Wang Y; Yang L; Huang S; Fu X
Int J Low Extrem Wounds; 2015 Mar; 14(1):50-62. PubMed ID: 25858630
[TBL] [Abstract][Full Text] [Related]
34. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
35. Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation.
Cai G; Zhang X; Hong Q; Shao F; Shang X; Fu B; Feng Z; Lin H; Wang J; Shi S; Yin Z; Chen X
Nephrol Dial Transplant; 2008 Jun; 23(6):1861-75. PubMed ID: 18326884
[TBL] [Abstract][Full Text] [Related]
36. [The effect of bone marrow mesenchymal stem cell transplantation on diabetic cardiomyopathy].
ZHANG N; LI JH; WANG JA; ZHANG HK
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1115-9. PubMed ID: 19134282
[TBL] [Abstract][Full Text] [Related]
37. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in the collagen-degrading ability of Porphyromonas gingivalis-stimulated human gingival fibroblasts.
Zhou J; Windsor LJ
J Periodontal Res; 2007 Feb; 42(1):77-84. PubMed ID: 17214643
[TBL] [Abstract][Full Text] [Related]
40. Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells.
Kim YS; Kwon JS; Hong MH; Kim J; Song CH; Jeong MH; Cho JG; Park JC; Kang JC; Ahn Y
Artif Organs; 2010 Jun; 34(6):453-61. PubMed ID: 20624160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
